EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial

Elena Ermolenko, Stanislav Sitkin iD, Lyubov Alferova iD, Nadezhda Novikova iD, Nikita Gladyshev iD, Victoria Orlova iD, Alena Zalicheva iD, Elena Demchenko iD, Oleg Ergashev, Alexander Suvorov iD

Nutrients · 16.07.2026 · 18 (14) · 2324

DOI: 10.3390/nu18142324 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 16.07.2026. Verfasst von Elena Ermolenko und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Medicine, St. Petersburg 197376, Russia. Hauptthemen laut MEDLINE: Metabolic Syndrome, Obesity, Gastrointestinal Microbiome, Lipid Metabolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Experimental Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: A pilot study was conducted to evaluate the effectiveness of treatment with autoprobiotic bacteria from indigenous, non-pathogenic Enterococcus faecium and Enterococcus hirae strains in patients with metabolic syndrome (MetS).

Methods

Fifty patients with MetS (sex-matched, aged 42–63 years) were randomized to an experimental group (Ap, n = 26) that received autoprobiotics grown in nutritional mix SuproPlus 2640 and a control group (Pl, n = 24) that received SuproPlus 2640 for 20 days.

Results

The effects of therapy on anthropometric and biochemical parameters, as well as the gut microbiome, were assessed on days 14 and 28 after the autoprobiotic course. Autoprobiotic treatment reduced the severity of obesity symptoms and led to decreases in serum glucose and glycated hemoglobin (HbAc1) levels and partial normalization of the lipid profile. An intergroup comparison revealed lower concentrations of HbAc1 and triglycerides in blood serum when comparing samples taken from Ap and Pl groups on day 28 after therapy. qPCR showed a reduction in the numbers of Bacteroides fragilis group, Streptococcus spp., and Ruminococcus spp. in the Ap group. The 16S rRNA gene sequencing results provided a longitudinal model for relative abundance analysis of the observed taxa, and comparison between dynamic parameters indicated a more favorable trend in the Ap group, with a decrease in the relative abundance of Oscillospiraceae UCG-003 and an increase in that of “Prevotellamassilia” observed only in this group. Longitudinal microbiota analysis using the coda4microbiome package demonstrated that the most pronounced microbiome shifts occurred in the Ap group, with the genera Senegalimassilia, “Prevotellamassilia”, Streptococcus, Paraprevotella, and Anaerobutyricum contributing substantially.

Conclusions

Autoprobiotic Enterococcus spp. may affect the gut microbiome and is potentially effective for treating MetS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeObesityGastrointestinal MicrobiomeLipid MetabolismProbioticsCarbohydrate MetabolismDietary SupplementsHumansPilot ProjectsAdultMiddle AgedFemaleMaleEnterococcus faeciumBlood GlucoseGlycated HemoglobinTreatment Outcome

Stichwörter der Autor:innen

Bacteroides fragilis groupEnterococcus spp.Oscillospiraceae UCG-003Senegalimassiliaautoprobioticfecal microbiotaglucoselipid metabolismmetabolic syndromeobesity

Substanzen

Blood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • Institute of Experimental Medicine, St. Petersburg 197376, Russia.
  • Department of Medical Microbiology, North-Western State Medical University Named After I.I. Mechnikov, St. Petersburg 191015, Russia.
  • Department of Internal Diseases, Gastroenterology and Dietetics Named After S.M. Ryss, North-Western State Medical University Named After I.I. Mechnikov, St. Petersburg 191015, Russia.
  • Almazov National Medical Research Centre, St. Petersburg 197341, Russia.
  • Petrovsky National Research Centre of Surgery, Moscow 117418, Russia.

ORCID-Profile: Stanislav Sitkin, Lyubov Alferova, Nadezhda Novikova, Nikita Gladyshev, Victoria Orlova, Alena Zalicheva, Elena Demchenko, Alexander Suvorov

Förderung

  • Institute of Experimental Medicine

Zitieren

APA

Ermolenko, E., Sitkin, S., Alferova, L., Novikova, N., Gladyshev, N., Orlova, V., Zalicheva, A., Demchenko, E., Ergashev, O., & Suvorov, A. (2026). Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial. Nutrients, 18(14), 2324. https://doi.org/10.3390/nu18142324

Vancouver

Ermolenko E, Sitkin S, Alferova L, Novikova N, Gladyshev N, Orlova V, et al. Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial. Nutrients. 2026;18(14):2324. doi:10.3390/nu18142324

BibTeX
@article{Ermolenko2026,
  author = {Ermolenko, Elena and Sitkin, Stanislav and Alferova, Lyubov and Novikova, Nadezhda and Gladyshev, Nikita and Orlova, Victoria and Zalicheva, Alena and Demchenko, Elena and Ergashev, Oleg and Suvorov, Alexander},
  title = {Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {14},
  pages = {2324},
  doi = {10.3390/nu18142324}
}
Kostenlos starten →